Prostate Cancer: Men Should Skip Common Blood Test, Panel Says
Men should not be screened for prostate cancer with a common blood test, a widely followed federal advisory panel recommended Monday. But the report is not likely to quell a dispute about whether the test’s risks outweigh its potential benefits. The US Preventive Services Task Force recommended a “D” grade for prostate-specific-antigen, or PSA, testing
2 min read